Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.
about
Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han populationAssociation between the Cytotoxic T-lymphocyte antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis.Autoimmune effector memory T cells: the bad and the goodAntibody-based immunotherapy for malignant glioma.CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors.Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studiesCytotoxic T lymphocyte-associated antigen-4 +49A>G polymorphism and the risk of non-small cell lung cancer in a Chinese populationThe prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis.Recipient cytotoxic T lymphocyte antigen 4 +49 single-nucleotide polymorphism is not associated with acute rejection after liver transplantation in Chinese populationAnalysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomasCytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis.Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma.Association of CTLA-4 gene polymorphisms -318C/T and +49A/G and Hashimoto's thyroidits in Zahedan, Iran.Improving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignancies.Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study.Lack of association between cytotoxic T-lymphocyte antigen-4 gene polymorphisms and lymphoid malignancy risk: evidence from a meta-analysis.Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs' activation and function.Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women.Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma.Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.High CTLA-4 expression correlates with poor prognosis in thymoma patients.CTLA4 A49G polymorphism shows significant association with glioma risk in a Chinese population.Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patientsCTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancersPotential function of CTLA-4 in the tumourigenic capacity of melanoma stem cells
P2860
Q33297928-440F7B68-BDA1-4DAF-90DD-EDDA29E5ABA9Q33710123-61D19D37-F2C2-4AAD-8C3A-EF48DAB99518Q33794691-F6910ACD-8F74-4B5F-9D4A-8C137B11F95DQ34120472-B58BA431-B091-4F81-8DB9-73BAAC5A3C1AQ34631546-FF8512B7-433E-4A83-8270-90A4CB5B1C29Q35101747-175A7990-F947-4012-9084-20A839BCA402Q35870600-DE328976-ED09-4263-983D-2EB677535FEBQ36046801-1C344AC0-11A9-4D93-86F2-5D398C5DDFBAQ36283876-B9ECAF60-516B-46CE-8EFE-A97B08E27B3BQ36572966-302ED66E-CB80-405A-867A-EB88129ADA48Q37266079-2D012AE4-2BF2-4795-AADD-8E57AAC9BB4DQ37295753-B919BB92-7C61-4033-9772-4803FD9B5E38Q37345560-0FDEA18B-00C7-496E-A8E3-D2D15C4964ADQ37593860-A512FCD7-0F22-4A2E-B993-0AC55B4D1807Q38799409-2C50A407-619A-4FFE-85C0-9AE8C063EB31Q39134477-3C7D1DD7-4F70-49EB-827F-46DF4892F08BQ39515498-62649853-2A75-4C07-84C0-7918F0C2CCC4Q45395844-AC50CB8C-85A6-4A40-BE8D-EB03C411D71EQ46879549-82EC9CE1-3CC2-4C6D-8700-2BB595F2D2ADQ49391905-48260CA7-D805-4B55-B446-E48123BBC0F2Q50928165-C14F4B7A-FA67-4824-B564-A029D9508C55Q52577907-231CB327-73E6-45E7-8F49-3429EBF900B8Q53336075-53A19B8D-C141-4C85-8788-5B36E2A622E3Q53671143-3446476F-2A9F-4FAD-92D9-F7A27C65D324Q54229184-73167AB9-B9F5-49F5-9B2F-985866945F73Q54943060-3B17D645-947F-45F8-AFF3-D6B35D863F38Q55463567-60D2FC2C-CBA0-4378-9161-ADD1538F773FQ56897193-5E9B0FF7-D672-446D-8DE9-41A3B8629FF7Q56900986-E19F0A8B-B460-4814-B6FA-5F62F76F2CDFQ57788678-50A9BE7D-C8D3-4360-A1E2-64AC57E1A26F
P2860
Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cytotoxic T-lymphocyte antigen ...... ity to non-Hodgkin's lymphoma.
@en
type
label
Cytotoxic T-lymphocyte antigen ...... ity to non-Hodgkin's lymphoma.
@en
prefLabel
Cytotoxic T-lymphocyte antigen ...... ity to non-Hodgkin's lymphoma.
@en
P2093
P356
P1476
Cytotoxic T-lymphocyte antigen ...... ity to non-Hodgkin's lymphoma.
@en
P2093
Angelo Palmas
Annalisa Noli
Attilio Gabbas
Giancarlo Latte
Luigi Arru
Marco Murineddu
Maria Monne
P2860
P356
10.1002/AJH.20045
P577
2004-05-01T00:00:00Z